Hila Karah - DarioHealth Corp Director

DRIO Stock  USD 1.52  0.03  2.01%   

Director

Ms. Hila Karah is Independent Director of the Company. Ms. Karah is an independent business consultant and an investor in several hightech, biotech and internet companies. From 2006 to 2013, she served as a partner and Chief Investment Officer of Eurotrust Ltd., a family office. From 2002 to 2005, she served as a research analyst at Perceptive Life Sciences Ltd., a New Yorkbased hedge fund. Prior to that, Ms. Karah served as research analyst at Oracle Partners Ltd., a health carefocused hedge fund. Ms. Karah has served as a director in several private and public companies including Intec Pharma, since 2009 and Cyren Ltd since 2008 since 2014.
Age 47
Tenure 10 years
Address 18 West 18th Street, New York, NY, United States, 10011
Phone833 914 3796
Webhttps://www.dariohealth.com
Karah holds a B.A. in Molecular and Cell Biology from the University of California, Berkeley, and studied at the University of California, BerkeleyUniversity of California, San Francisco Joint Medical Program. We believe Ms. Karah is qualified to serve on our Board because of her experience as an investor in and advisor to hightech, biotech and Internet companies.

DarioHealth Corp Management Efficiency

The company has return on total asset (ROA) of (0.2737) % which means that it has lost $0.2737 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7359) %, meaning that it created substantial loss on money invested by shareholders. DarioHealth Corp's management efficiency ratios could be used to measure how well DarioHealth Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of March 2024, Return On Capital Employed is likely to drop to -0.54. In addition to that, Return On Assets is likely to drop to -0.49. At this time, DarioHealth Corp's Fixed Asset Turnover is very stable compared to the past year. As of the 28th of March 2024, Asset Turnover is likely to grow to 0.39, while Non Currrent Assets Other are likely to drop about 86 K.
The company currently holds 28.05 M in liabilities with Debt to Equity (D/E) ratio of 0.23, which may suggest the company is not taking enough advantage from borrowing. DarioHealth Corp has a current ratio of 6.22, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist DarioHealth Corp until it has trouble settling it off, either with new capital or with free cash flow. So, DarioHealth Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DarioHealth Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DarioHealth to invest in growth at high rates of return. When we think about DarioHealth Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Dipchand NisharGuardant Health
N/A
Richelle ParhamLaboratory
53
Donna ShalalaMednax Inc
75
Robert WilliamsLaboratory
72
Donna ZarconeCigna Corp
63
Mark McClellanCigna Corp
57
George KurianCigna Corp
54
Pascal GoldschmidtMednax Inc
65
Garheng KongLaboratory
45
Michelle GassCigna Corp
47
Michael FernandezMednax Inc
66
Aaref HilalyGuardant Health
46
Stanley MeresmanGuardant Health
71
JeanLuc BelingardLaboratory
72
Manuel KadreMednax Inc
54
Waldemar CarloMednax Inc
67
Kimberly RossCigna Corp
56
Gary GillilandLaboratory
63
William ZollarsCigna Corp
70
Roman MartinezCigna Corp
71
Ian ClarkGuardant Health
57
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Dario Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 200 people. DarioHealth Corp (DRIO) is traded on NASDAQ Exchange in USA. It is located in 18 West 18th Street, New York, NY, United States, 10011 and employs 241 people. DarioHealth Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

DarioHealth Corp Leadership Team

Elected by the shareholders, the DarioHealth Corp's board of directors comprises two types of representatives: DarioHealth Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DarioHealth. The board's role is to monitor DarioHealth Corp's management team and ensure that shareholders' interests are well served. DarioHealth Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DarioHealth Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Glen Moller, Director
Josh Fischer, Senior Compliance
Dov Oppenheim, CoFounder Chief
Rami Yehudiha, Director
Hila Karah, Director
Richard Anderson, President
Claudia Levi, Content Manager
Jean Muyl, Head America
Zvi David, Treasurer CFO
Yalon Farhi, Director
Erez Raphael, Chairman, CEO and Pres
Ori Zanco, Director
Mary Mooney, Vice Marketing
Limor Drezner, Chief Officer
Dennis McGrath, Director
Olivier Jarry, President and Chief Commercial Officer
Malcolm Hoenlein, Independent Director
Richard Stone, Independent Director
Tomer BenKiki, Chief Officer
Brian Harrigan, Senior Sales
Yossi Bahagon, Director
Yoav Shaked, Chairman of the Board
Dror Bacher, Chief Officer
Zvi BenDavid, CFO, Treasurer, Secretary
Allen Kamer, Director
Omar MD, Chief Officer

DarioHealth Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DarioHealth Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with DarioHealth Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.

Moving together with DarioHealth Stock

  0.85MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr

Moving against DarioHealth Stock

  0.48FEMY Femasys Report 4th of April 2024 PairCorr
  0.46CVS CVS Health Corp Financial Report 1st of May 2024 PairCorr
  0.42NVNO EnVVeno Medical Corp Financial Report 6th of May 2024 PairCorr
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for DarioHealth Stock analysis

When running DarioHealth Corp's price analysis, check to measure DarioHealth Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DarioHealth Corp is operating at the current time. Most of DarioHealth Corp's value examination focuses on studying past and present price action to predict the probability of DarioHealth Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DarioHealth Corp's price. Additionally, you may evaluate how the addition of DarioHealth Corp to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Is DarioHealth Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.04)
Revenue Per Share
0.852
Quarterly Revenue Growth
(0.47)
Return On Assets
(0.27)
Return On Equity
(0.74)
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.